Cellectis, genOway functional genomics news

Paris' Tribunal de Grande Instance dismissed genOway's lawsuit that challenged Cellectis' termination of a 2001 deal between the companies. In January, Cellectis ended its non-exclusive license deal with genOway, covering the use of homologous recombination for cellular and animal model development, alleging that genOway used the technology outside the licensed field (see BioCentury, Jan. 12). ...